Generation of endoplasmic reticulum stress and inhibition of autophagy by plitidepsin induces proteotoxic apoptosis in cancer cells - ScienceDirect
PharmaMar discovers new data on the mechanism | EurekAlert!
Exploring the effect of aplidin on low molecular weight protein tyrosine phosphatase by molecular docking and molecular dynamic simulation study - ScienceDirect
Repurposing anticancer drugs for the management of COVID-19 - ScienceDirect
Effect of Aplidin on MM cells stimulated with proliferative cytokines... | Download Scientific Diagram
Activity of Aplidin on MM cell lines. A, dose-response matrix of human... | Download Scientific Diagram
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Plitidepsin mechanism of action. | Download Scientific Diagram
Marine Drugs | Free Full-Text | Antitumor Peptides from Marine Organisms | HTML
Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™ | British Journal of Cancer
Dehydrodidemnin B - an overview | ScienceDirect Topics
Oncology clinical pipeline marine inspired drugs | PharmaMar
Plitidepsin: design, development, and potential place in therapy | DDDT
Plitidepsin: design, development, and potential place in therapy | DDDT
Frontiers | Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics | Immunology
Frontiers | Exploring the Diversity of the Marine Environment for New Anti-cancer Compounds | Marine Science
Oxidation and inactivation of low molecular weight protein tyrosine phosphatase by the anticancer drug Aplidin - Taddei - 2006 - International Journal of Cancer - Wiley Online Library
Role of Cu 2+ in Aplidin s -induced apoptosis in MDA-MB-231 cells | Download Table
Oxidation and inactivation of low molecular weight protein tyrosine phosphatase by the anticancer drug Aplidin - Taddei - 2006 - International Journal of Cancer - Wiley Online Library
Aplidin, plitidepsin, as PM90001 | PharmaMar
Molecules | Free Full-Text | Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective | HTML
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) | Leukemia
Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II study - Annals of Oncology
Phamamar achieve to extend the comercialization of its marine derived anti cancer drugs over eleven latinamerican countries.
Aplidin, plitidepsin, as PM90001 | PharmaMar
Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts. - Abstract - Europe PMC
